Lennham Pharmaceuticals, Inc. – Trademark Portfolio
Entity Type: 03
Lennham Pharmaceuticals, Inc. owns a portfolio of 13 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as D9, DEURA9, ELUSTRA, and COLD FUSION. Of these, 4 are registered and 3 are pending. The portfolio spans 7 Nice Classification classes, led by Class 32 (Light Beverages) and Class 1 (Chemicals). Headquartered in Concord, MA.
53 Main Street, Suite 206
Concord, MA 01742
Showing of trademarks Trademarks
Trademark Classifications
Lennham Pharmaceuticals, Inc.'s trademark portfolio spans 7 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Lennham Pharmaceuticals, Inc. have?
Lennham Pharmaceuticals, Inc. has 13 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 pending, 6 abandoned.
What trademark classes does Lennham Pharmaceuticals, Inc. file in?
Lennham Pharmaceuticals, Inc. files trademarks across 7 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 29 (Meats & Processed Foods). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.
What are Lennham Pharmaceuticals, Inc.'s most well-known trademarks?
Lennham Pharmaceuticals, Inc.'s registered trademark portfolio includes well-known marks such as D9, DEURA9, ELUSTRA, and COLD FUSION. These are among 4 currently registered trademarks in the portfolio.
What is Lennham Pharmaceuticals, Inc.'s trademark registration success rate?
Lennham Pharmaceuticals, Inc. has a 40% trademark registration rate, with 4 out of 10 resolved applications resulting in successful registration. Currently, 3 applications are pending review.